ArticleInternational journal of molecular sciences2017

Human CD3+ T-Cells with the Anti-ERBB2 Chimeric Antigen Receptor Exhibit Efficient Targeting and Induce Apoptosis in ERBB2 Overexpressing Breast Cancer Cells.

Rusheni Munisvaradass et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.